Latest Spinogenix News & Updates

See the latest news and media coverage for Spinogenix. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Spinogenix

Synaptic regenerative therapeutics for brain disorders

spinogenix.com
Headquarters
Los Angeles, United States
Founded year
2016
Company type
Private company
Number of employees
4–10
Industry
Pharmaceuticals

Last updated

Latest news about Spinogenix

In short: Spinogenix advanced its synaptic regenerative pipeline, reporting positive clinical data for tazbentetol in ALS and Alzheimer’s disease.

Company announcements

Spinogenix

Spinogenix founder speaks at symposium

Stella Sarraf shares her journey and Spinogenix's progress in synapse regeneration for ALS, Alzheimer’s, schizophrenia, and Fragile X, with positive trial readouts.

Unlock all announcements with a

Media coverage

Yahoo Finance

Spinogenix to Present Preclinical Results at ARVO 2026 Demonstrating Neuroprotective Effects of Tazbentetol in Glaucoma and Diabetic Retinopathy Models

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, will present this week the results...

Unlock all articles with a

Never miss news about Spinogenix

Track Spinogenix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.